VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.50
+0.51%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.52x
- Debt / assets
- 0.05x
- Debt / EBITDA
- 0.17x
- Net debt / EBITDA
- -0.91x
Liquidity & coverage
- Current ratio
- 1.60x
- Quick ratio
- 1.60x
- Cash ratio
- 0.88x
- Interest coverage
- 18.03x
- EBITDA / interest
- 21.49x
- Working capital
- $43.6M
Cash & dividend
- FCF / debt
- 4.28x
- Cash flow / debt
- 4.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026